Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Susan Latter"'
Autor:
Clare Harris, Richard James Harris, David Young, Martin McDonnell, Bridget Clancy, Justin Harvey, Carlos Araujo, Ines Iria, Joao Goncalves, Susan Latter, J. R. Fraser Cummings
Publikováno v:
GastroHep, Vol 2023 (2023)
Background and Aims. Regulatory pathways compare biosimilars with originator molecules only and not with other biosimilars. With the development of multiple infliximab biosimilars, patients may be asked to transition between them. Data is emerging bu
Externí odkaz:
https://doaj.org/article/61a1e3a05a274fc48c97283fd25c76bd
Autor:
Natasha Campling, Liz Breen, Elizabeth Miller, Jacqueline Birtwistle, Alison Richardson, Michael Bennett, Susan Latter
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 6, Iss , Pp 100132- (2022)
Background: Patient access to medicines in the community at end-of-life (pertaining to the last year of life) is vital for symptom control. Supply of such medicines is known to be problematic, but despite this, studies have failed to examine the issu
Externí odkaz:
https://doaj.org/article/14d91e87d7ae4cc4865ae179d4b0764d
Publikováno v:
Poster presentations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24f74343e2d0f4b945f08b2e26172e2c
https://doi.org/10.1136/gutjnl-2022-bsg.278
https://doi.org/10.1136/gutjnl-2022-bsg.278
Publikováno v:
European journal of hospital pharmacy : science and practice.
Objectives: Transition from originator biological medicines to their biosimilar equivalents is now part of routine clinical practice, but there is little understanding of patient experiences, which influence adherence and overall satisfaction with ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43de90a57a73af452d5a1f0e1560a801
https://pubmed.ncbi.nlm.nih.gov/35853694
https://pubmed.ncbi.nlm.nih.gov/35853694
Autor:
Natasha Campling, Liz Breen, Elizabeth Miller, Jacqueline Birtwistle, Alison Richardson, Michael Bennett, Susan Latter
Publikováno v:
Exploratory research in clinical and social pharmacy. 6
Background: Patient access to medicines in the community at end-of-life (pertaining to the last year of life) is vital for symptom control. Supply of such medicines is known to be problematic, but despite this, studies have failed to examine the issu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03fd5d21b4c2a8da5328b54973ac26f1
https://pubmed.ncbi.nlm.nih.gov/35909712
https://pubmed.ncbi.nlm.nih.gov/35909712
Autor:
Mary M. Waldron, Elizabeth Beveridge, Vernon Udall, Victoria Susan Latter, R. A. Neal, I. C. Caldwell
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 74(1)
A novel 8-aminoquinolone compound, 8(6-4' 3-hydroxybutyl)piperazin-1'-ylhexylamino)-6-methoxyquinoline di(hydrogen maleate), moxipraquine, 349C59, was shown to be active against experimental infections with Trypanosoma cruzi. It was effective in supp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::997b1f583dc3aa8cc8362748d8ec7b7e
https://pubmed.ncbi.nlm.nih.gov/6776663
https://pubmed.ncbi.nlm.nih.gov/6776663
Autor:
Victoria Susan Latter
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 66(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9aa8b37e21948225f15b51ac6fe677b
https://pubmed.ncbi.nlm.nih.gov/4340171
https://pubmed.ncbi.nlm.nih.gov/4340171